BEPO® - An Enabling Long Acting Injectable Technology Platform for Drug Delivery Challenges

Sylvestre Grizot is a Principal Investigator at MedinCell (Jacou, France), where he is leading a research team around the formulation of peptides and therapeutic proteins with the aim of designing long acting injectables for better treatments and improved patient compliance. Prior to this position, he worked for several companies in the field of protein engineering. He holds a Master in Bioengineering from Ecole Centrale Paris, a Master of Science in Molecular Biophysics from University Paris VI and a PhD in protein biochemistry and crystallography from Grenoble University, France.